The use of<unk>  with penicillins has been associated with an increased incidence of cholestatic jaundice and acute hepatitis during therapy or shortly after. The associated jaundice is usually self-limiting and very rarely fatal. The UK Committee on Safety of Medicines (CSM) recommends that treatments such as amoxicillin/clavulanic<unk>  preparations be reserved for bacterial infections likely to be<unk> used by amoxicillin-resistant β-lactamase-producing strains, and that treatment should not normally exceed 14 days. Allergic reactions have been reported.
Clavulanic acid
Ampicillin
Piperacillin
Meropenem
Imipenem
Netilmicin
Cethromycin
Ceftazidime